Dr Lane wrote to Dr Rejman that the presence of antibody for Hepatitis C was not necessarily a marker of infectivity in HCV screening. However, Dr Gunson and the ACTTD were reporting the opposite of this, which Dr Mortimer and Professor Cash appeared to endorse.
Chronology Information
Date:
Chapter/issue
Hepatitis C Screening
Key Person(s)
Dr Richard S Lane
Dr Andrzej Rejman
Dr Harold H Gunson
Dr Philip Mortimer
Professor John D Cash